These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2856045)

  • 1. Nephrocalcinosis in children and adolescents: sonographic evaluation during long-term treatment with 1,25-dihydroxycholecalciferol.
    Weber G; Cazzuffi MA; Frisone F; de Angelis M; Pasolini D; Tomaselli V; Chiumello G
    Child Nephrol Urol; 1988-1989; 9(5):273-6. PubMed ID: 2856045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
    N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrocalcinosis in X-linked hypophosphataemic rickets: its relationship to treatment, kidney function, and growth.
    Kooh SW; Binet A; Daneman A
    Clin Invest Med; 1994 Apr; 17(2):123-30. PubMed ID: 8004848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrocalcinosis is associated with renal tubular acidosis in children with X-linked hypophosphatemia.
    Seikaly M; Browne R; Baum M
    Pediatrics; 1996 Jan; 97(1):91-3. PubMed ID: 8545232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrocalcinosis in X-linked hypophosphataemic rickets: just how serious is the problem?
    Cole DE
    Clin Invest Med; 1994 Apr; 17(2):131-2. PubMed ID: 8004849
    [No Abstract]   [Full Text] [Related]  

  • 7. The Impact of Hypoparathyroidism Treatment on the Kidney in Children: Long-Term Retrospective Follow-Up Study.
    Levy I; Licht C; Daneman A; Sochett E; Harrington J
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4106-13. PubMed ID: 26323021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypophosphatemic rickets: still misdiagnosed and inadequately treated.
    Greene WB; Kahler SG
    South Med J; 1985 Oct; 78(10):1179-84. PubMed ID: 2996152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Familial hypophosphatemic rickets. Effects of treatment with 1,25-dihydroxycholecalciferol at supraphysiologic doses].
    Saggese G; Baroncelli GI; Bertelloni S; Federico G
    Minerva Pediatr; 1987 May; 39(10):451-5. PubMed ID: 3657736
    [No Abstract]   [Full Text] [Related]  

  • 11. Guide-lines to the treatment of patients with X-linked hypophosphatemic rickets.
    Reusz GS
    Acta Biomed Ateneo Parmense; 1995; 66(3-4):147-51. PubMed ID: 8578931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutics of X-linked hypophosphatemic rickets.
    Latta K; Hisano S; Chan JC
    Pediatr Nephrol; 1993 Dec; 7(6):744-8. PubMed ID: 8130097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hereditary hypophosphatemic vitamin D resistant rickets with 1,25 dihydroxycholecalciferol--a new therapeutic possibility].
    Wigger M; Mix M; Richter I; Stolpe HJ; Adomssent G
    Kinderarztl Prax; 1984 Mar; 52(3):135-44. PubMed ID: 6328098
    [No Abstract]   [Full Text] [Related]  

  • 14. Dental abnormalities in patients with familial hypophosphatemic vitamin D-resistant rickets: prevention by early treatment with 1-hydroxyvitamin D.
    Chaussain-Miller C; Sinding C; Wolikow M; Lasfargues JJ; Godeau G; Garabédian M
    J Pediatr; 2003 Mar; 142(3):324-31. PubMed ID: 12640383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hypocalcemia caused by hypoparathyroidism or pseudohypoparathyroidism with domestic-made calcitriol: a prospective and self-controlled clinical trial.
    Wang O; Xing XP; Meng XW; Xia WB; Li M; Jiang Y; Hu YY; Liu HC
    Chin Med J (Engl); 2009 Feb; 122(3):279-83. PubMed ID: 19236804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe hypercalcemia in a patient treated for hypoparathyroidism with calcitriol.
    De Sanctis V; Fiscina B; Ciccone S
    Pediatr Endocrinol Rev; 2010 Jun; 7(4):363-5. PubMed ID: 20679997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated hypophosphataemic rickets.
    Reusz GS; Latta K; Hoyer PF; Byrd DJ; Ehrich JH; Brodehl J
    Lancet; 1990 May; 335(8700):1240-3. PubMed ID: 1971321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrocalcinosis and its relationship to treatment of hereditary rickets.
    Goodyer PR; Kronick JB; Jequier S; Reade TM; Scriver CR
    J Pediatr; 1987 Nov; 111(5):700-4. PubMed ID: 2822887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrocalcinosis, hyperparathyroidism, and renal failure in familial hypophosphatemic rickets.
    Alon U; Lovell HB; Donaldson DL
    Clin Pediatr (Phila); 1992 Mar; 31(3):180-3. PubMed ID: 1547591
    [No Abstract]   [Full Text] [Related]  

  • 20. Pseudohypoparathyroidism: report of seven cases.
    Chen YJ; Shu SG; Chi CS
    Acta Paediatr Taiwan; 2005; 46(6):374-80. PubMed ID: 16640041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.